Cardiva Medical has developed an innovative approach to safe, arteriotomy site-specific compression, hemostasis, boomerang effect, secure vascular closure without leaving anything behind in the artery or tissue tract.
 
 About Us   :   
 Products   :   
 Healthcare Professionals   :   
 Patients   :   
 Newsroom   :   
 Contact Us   
 
Spotlight: FDA APPROVES VASCADE™ VCS
Cardiva Catalyst™ Family
VASCADE™ VCS
The VASCADE™ Vascular closure System (VCS) is a new generation extravascular closure device designed to increase the comfort and safety of vascular closure for patients.
Cardiva Catalyst™ Family
Cardiva Catalyst™ Family
The Cardiva Catalyst™ is designed to increase the comfort of the manual compression process and facilitate the body’s healing process.
Ordering
Ordering
For order information, please contact Cardiva Customer Service
1-866-602-6099
News & Events
January 20, 2014
Cardiva Medical, Inc. Announces Appointment of Randy Hubbell, Chief Commercial Officer
February 6, 2013
Cardiva Medical, Inc. Announces FDA approval of VASCADE™ Vascular Closure System
September 25, 2012
Cardiva Medical, Inc. announces that it has obtained approval to apply the European CE Mark to its VASCADE™ Vascular Closure System (VCS)
August 9, 2012
Cardiva Medical, Inc. Completes Third Tranche of Series 2 Private Equity Financing
August 2, 2012
Cardiva Medical, Inc. submits final PMA module to FDA for VASCADE™ Vascular Closure System
June 20, 2012
Cardiva Medical, Inc. Announces Completion of Enrollment in the RESPECT Clinical Trial Aimed at Demonstrating the Safety and Efficacy of the VASCADE™ Vascular Closure System

 

 2013  Cardiva Medical, Inc.  
   :    Privacy Policy